New York State Teachers Retirement System Sells 1,100 Shares of Certara, Inc. (NASDAQ:CERT)

New York State Teachers Retirement System lessened its stake in Certara, Inc. (NASDAQ:CERT) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 62,704 shares of the company’s stock after selling 1,100 shares during the period. New York State Teachers Retirement System’s holdings in Certara were worth $668,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Blue Trust Inc. raised its position in Certara by 20.9% in the 4th quarter. Blue Trust Inc. now owns 4,747 shares of the company’s stock worth $56,000 after purchasing an additional 822 shares during the last quarter. Nicolet Advisory Services LLC raised its position in shares of Certara by 6.6% during the 3rd quarter. Nicolet Advisory Services LLC now owns 24,831 shares of the company’s stock valued at $273,000 after acquiring an additional 1,531 shares during the last quarter. KBC Group NV raised its position in shares of Certara by 48.2% during the 3rd quarter. KBC Group NV now owns 4,873 shares of the company’s stock valued at $57,000 after acquiring an additional 1,584 shares during the last quarter. Harbor Capital Advisors Inc. raised its position in shares of Certara by 18.4% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 20,144 shares of the company’s stock valued at $236,000 after acquiring an additional 3,136 shares during the last quarter. Finally, Atria Investments Inc raised its position in shares of Certara by 21.6% during the 3rd quarter. Atria Investments Inc now owns 19,743 shares of the company’s stock valued at $231,000 after acquiring an additional 3,501 shares during the last quarter. Institutional investors own 73.96% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on CERT shares. Barclays dropped their target price on shares of Certara from $14.00 to $12.00 and set an “equal weight” rating for the company in a research report on Thursday, November 7th. Robert W. Baird dropped their target price on shares of Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $15.92.

Certara Stock Performance

NASDAQ CERT opened at $13.17 on Monday. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $2.12 billion, a price-to-earnings ratio of -65.85, a P/E/G ratio of 9.29 and a beta of 1.57. The firm’s 50 day simple moving average is $12.32 and its 200 day simple moving average is $11.63. Certara, Inc. has a 1 year low of $9.41 and a 1 year high of $19.87.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.